Adial Pharmaceuticals Inc (NASDAQ:ADIL) price target set to $5.00 by Maxim Group

Analyst Ratings For Adial Pharmaceuticals Inc (NASDAQ:ADIL)

Story continues below

Today, Maxim Group set its price target on Adial Pharmaceuticals Inc (NASDAQ:ADIL) to $5.00 per share.

There are 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Adial Pharmaceuticals Inc (NASDAQ:ADIL) is Buy with a consensus target price of $5.00 per share, a potential 48.81% upside.

Some recent analyst ratings include

  • 10/11/2018-Adial Pharmaceuticals Inc (NASDAQ:ADIL) has coverage initiated with a Buy rating

    Recent Trading Activity for Adial Pharmaceuticals Inc (NASDAQ:ADIL)
    Shares of Adial Pharmaceuticals Inc closed the previous trading session at 3.36 up +1.33 65.52% with 3.99 shares trading hands.

    An ad to help with our costs